Skip to main content

Table 1 Clinico-pathological features of patients (n=72)

From: Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study

Items

Characteristics

Lung cancer patients (N=72)

Healthy individuals (N=60)

Gender

 

Male

46(63.9%)

38(63.3%)

 

Female

26(36.1%)

22(36.7%)

Ages

 

<60

31(43.06%)

36(60%)

 

≥60

41(56.94%)

24(40%)

Smoking

 

Yes

28(38.9%)

19 (31.7%)

 

No

44(61.1%)

41(68.3%)

Classification of pathology

 

LAC

33(45.83%)

 
 

LSCC

39(54.17%)

 

Differentiation degree

 

Poorly differentiated

24(33.3%)

 
 

Moderately differentiated

19(26.4%)

 
 

Well-differentiated

29(40.3%)

 

Clinical staging

 

IIA - IIIA

35(48.6%)

 
 

IIIB - IV

37(51.4%)

 

Lymphatic metastasis

 

N0 - N1

26(63.9%)

 
 

N2 - N3

46(36.1%)

 
  1. NSCLC, non-small cell lung cancer; LAC, lung adenocarcinoma; LSCC, lung squamous cell carcinoma; N, the grade of lymphatic invasion